Oncologic Emergencies

David A. Wacker, Michael T. McCurdy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

As improved therapy prolongs the lives of cancer patients, the prevalence of oncologic emergencies continues to increase. However, nonspecific clinical features misattributed to the underlying cancer complicate their diagnosis. In this chapter, we review febrile neutropenia, metastatic spinal cord compression (MSCC), malignant pericardial disease, hypercalcemia of malignancy, tumor lysis syndrome (TLS), leukostasis, superior vena cava (SVC) syndrome, and complications of cancer immunotherapies such as monoclonal antibodies, T-lymphocyte checkpoint inhibition, and adoptive cell transfer therapy.

Original languageEnglish (US)
Title of host publicationRosen's Emergency Medicine
Subtitle of host publicationConcepts and Clinical Practice: 2-Volume Set
PublisherElsevier
Pages1500-1516.e4
ISBN (Electronic)9780323757898
ISBN (Print)9780323757904
DOIs
StatePublished - Jan 1 2022

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Inc. All rights reserved.

Keywords

  • CAR T-cell therapy
  • Febrile neutropenia
  • Metastatic spinal cord compression
  • Monoclonal antibody therapy
  • Oncologic emergencies
  • T-cell checkpoint inhibitor therapy
  • Tumor lysis syndrome

Fingerprint

Dive into the research topics of 'Oncologic Emergencies'. Together they form a unique fingerprint.

Cite this